𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth Hormone Inhibits Tumor Metastasis

✍ Scribed by Michael H. Torosian; Robert B. Donoway


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
419 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


The effect of growth hormone on tumor growth and metabolism in the tumorbearing host is unknown. This study was done to determine the effect of recombinant growth hormone on primary tumor growth, tumor metastasis, and carcass weight in tumor-bearing animals. Twenty-seven female Lobund/Wistar rats with subcutaneous prostate tumor implants (PA-111) were randomized to receive a standard protein diet (22.0% protein; 4.27 kcal/g) or an isocaloric, protein-depleted diet (0.03% protein; 4.27 kcal/g) a d libitum orally. One half of the animals in each group were randomized to receive daily injections of either recombinant growth hormone (1000 mU/kg/day intramuscularly) or placebo (saline) for 14 days. A significant increase in body weight was observed in growth hormone-treated animals without acceleration of primary tumor growth. Spontaneous pulmonary metastasis was inhibited significantly in animals in both dietary groups treated with growth hormone. Thus, growth hormone selectively supports host growth and inhibits pulmonary metastasis in this tumor-bearing animal model. The potential metabolic effects and clinical consequences of treating cancer patients with growth hormone is discussed.


πŸ“œ SIMILAR VOLUMES


Nitroxyl inhibits breast tumor growth an
✍ Andrew J. Norris; Maryam R. Sartippour; Ming Lu; Taylor Park; Jian Yu Rao; Matth πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 245 KB

## Abstract Nitroxyl (HNO) can inhibit the glycolytic enzyme glyceraldehyde 3‐phosphate dehydrogenase (GAPDH). Because of the importance of glycolysis in many malignant cells, we thus propose that HNO can adversely affect tumor growth. This hypothesis was tested using __in vitro__ and __in vivo__ m

Ξ±1-antitrypsin inhibits angiogenesis and
✍ Hanhua Huang; Steven C. Campbell; Thomas Nelius; Dhugal F. Bedford; Dorina Velic πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 322 KB

## Abstract Disturbances of the ratio between angiogenic inducers and inhibitors in tumor microenvironment are the driving force behind angiogenic switch critical for tumor progression. Angiogenic inhibitors may vary depending on organismal age and the tissue of origin. We showed that Ξ±~1~‐antitryp